1. Home
  2. QLGN vs TRNR Comparison

QLGN vs TRNR Comparison

Compare QLGN & TRNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QLGN
  • TRNR
  • Stock Information
  • Founded
  • QLGN 1996
  • TRNR 2017
  • Country
  • QLGN United States
  • TRNR United States
  • Employees
  • QLGN N/A
  • TRNR N/A
  • Industry
  • QLGN Biotechnology: Pharmaceutical Preparations
  • TRNR Consumer Electronics/Appliances
  • Sector
  • QLGN Health Care
  • TRNR Technology
  • Exchange
  • QLGN Nasdaq
  • TRNR Nasdaq
  • Market Cap
  • QLGN 7.4M
  • TRNR 5.9M
  • IPO Year
  • QLGN N/A
  • TRNR 2023
  • Fundamental
  • Price
  • QLGN $2.85
  • TRNR $2.47
  • Analyst Decision
  • QLGN
  • TRNR
  • Analyst Count
  • QLGN 0
  • TRNR 0
  • Target Price
  • QLGN N/A
  • TRNR N/A
  • AVG Volume (30 Days)
  • QLGN 3.4M
  • TRNR 70.1K
  • Earning Date
  • QLGN 11-14-2025
  • TRNR 11-14-2025
  • Dividend Yield
  • QLGN N/A
  • TRNR N/A
  • EPS Growth
  • QLGN N/A
  • TRNR N/A
  • EPS
  • QLGN N/A
  • TRNR N/A
  • Revenue
  • QLGN N/A
  • TRNR $6,972,000.00
  • Revenue This Year
  • QLGN N/A
  • TRNR $578.14
  • Revenue Next Year
  • QLGN N/A
  • TRNR $130.65
  • P/E Ratio
  • QLGN N/A
  • TRNR N/A
  • Revenue Growth
  • QLGN N/A
  • TRNR 373.32
  • 52 Week Low
  • QLGN $1.61
  • TRNR $2.25
  • 52 Week High
  • QLGN $8.81
  • TRNR $106.30
  • Technical
  • Relative Strength Index (RSI)
  • QLGN 39.72
  • TRNR 31.33
  • Support Level
  • QLGN $2.66
  • TRNR $2.68
  • Resistance Level
  • QLGN $3.36
  • TRNR $3.02
  • Average True Range (ATR)
  • QLGN 0.55
  • TRNR 0.26
  • MACD
  • QLGN -0.17
  • TRNR -0.04
  • Stochastic Oscillator
  • QLGN 5.74
  • TRNR 18.33

About QLGN Qualigen Therapeutics Inc.

Qualigen Therapeutics Inc is an early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's program, QN-302, is an investigational small-molecule G-quadruplexes (G4)-selective transcription inhibitor with binding affinity to G4s prevalent in cancer cells.

About TRNR Interactive Strength Inc.

Interactive Strength Inc provides an integrated home fitness platform that allows its customers to participate in interactive wellness and strength-based training sessions. Its health coaching services encompass guidance and coaching on nutrition, recovery, sleep, and other health and lifestyle categories. The company generates revenue from sales of its connected fitness products, membership revenue, and personal training revenue.

Share on Social Networks: